Vinflunine in the treatment of bladder cancer.

Ther Clin Risk Manag · 2008 · PMC2643105 · PMID 19337431

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Analyzing the intent-to-treat-population, the 2-month survival advantage for arm A was achieved (6.9 vs 4.6 months), but did not reach statistical significance (p value 0.29).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.